Natural Product: NPC546553

Natural Product IDNPC546553
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-5-[(2~{S},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-[[(2~{R},3~{R},4~{R},5~{S})-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
IUPAC Name 2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-5-[(2~{S},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-[[(2~{R},3~{R},4~{R},5~{S})-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QPXXNLYWPXJSCA-XRFMZOFTSA-N
Standard InCHI InChI=1S/C28H32O15/c1-37-12-6-18-21(14(30)8-17(41-18)11-3-4-16(38-2)13(29)5-11)19(7-12)42-28-26(36)24(34)23(33)20(43-28)10-40-27-25(35)22(32)15(31)9-39-27/h3-8,15,20,22-29,31-36H,9-10H2,1-2H3/t15-,20+,22+,23+,24-,25+,26+,27+,28+/m0/s1
SMILES COC1=CC(O[C@@H]2O[C@H](CO[C@H]3OC[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)=C2C(=O)C=C(C3=CC=C(OC)C(O)=C3)OC2=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   608.17 Volume:   560.823
?
Van der Waals volume.
Dense:   1.084 LogP:   0.886
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.408
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.496
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   8.0 Rigid Bonds:   30.0
TPSA:   227.2
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   7.0 Rings:   5.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.16 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.62 Fsp3:   0.464
MCE-18:   115.098
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.628 Fluc inhibitor:   0.284
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.962
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.827
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.039 Promiscuous compounds:   0.275

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.19 MDCK Permeability:   -5.298
Pgp-inhibitor:   0.001 Pgp-substrate:   0.813
PAMPA:   0.993
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.033
20% Bioavailability (F20%):   0.038 30% Bioavailability (F30%):   0.482
50% Bioavailability (F50%):   0.99

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.069
Plasma Protein Binding (PPB):   76.407% Volume Distribution (VD):   -0.266
Fu: 22.075%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.685
BSEP inhibitor:   0.779

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.012
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.016
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.997
HLM stability:   0.071
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.382 Half-life (T1/2):  4.709

ADMET: Toxicity

hERG Blockers:  0.025 hERG Blockers (10um):  0.256
Human Hepatotoxicity (H-HT):  0.547 Drug-induced Liver Injury (DILI):  0.881
AMES Toxicity:  0.879 Rat Oral Acute Toxicity:  0.036
Maximum Recommended Daily Dose:  0.181 Skin Sensitization:  0.977
Carcinogencity:  0.07 Eye Corrosion:  0.0
Eye Irritation:  0.477 Respiratory Toxicity:  0.037
Drug-induced Neurotoxicity:  0.003 Ototoxicity:  0.933
Hematotoxicity:  0.254 Drug-induced Nephrotoxicity:  0.644
Genotoxicity:  0.674 RPMI-8226 Immunitoxicity:  0.192
A549 Cytotoxicity:  0.095 Hek293 Cytotoxicity:  0.253
BCF:   0.326
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.973
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.46
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.724
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1618 Ovidia pillo-pillo Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO1618 Ovidia pillo-pillo Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC546553 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8554 High Similarity NPC295613
0.8353 Intermediate Similarity NPC129827
0.8161 Intermediate Similarity NPC284277
0.8118 Intermediate Similarity NPC473657
0.7931 Intermediate Similarity NPC473512
0.7816 Intermediate Similarity NPC15358
0.7753 Intermediate Similarity NPC475497
0.6842 Remote Similarity NPC209296
0.6632 Remote Similarity NPC475366
0.6383 Remote Similarity NPC51774
0.6327 Remote Similarity NPC51326
0.6304 Remote Similarity NPC293004
0.6211 Remote Similarity NPC236191
0.6022 Remote Similarity NPC284960
0.6 Remote Similarity NPC52353
0.5979 Remote Similarity NPC301683
0.5918 Remote Similarity NPC22062
0.5918 Remote Similarity NPC473634
0.5918 Remote Similarity NPC138811
0.5806 Remote Similarity NPC182045
0.5728 Remote Similarity NPC231194
0.57 Remote Similarity NPC204693
0.5699 Remote Similarity NPC610763
0.5684 Remote Similarity NPC22832
0.5657 Remote Similarity NPC142996
0.5631 Remote Similarity NPC488089
0.56 Remote Similarity NPC210073
0.5567 Remote Similarity NPC194483
0.5534 Remote Similarity NPC473623
0.5534 Remote Similarity NPC483707
0.5534 Remote Similarity NPC473327
0.55 Remote Similarity NPC44931
0.549 Remote Similarity NPC488074
0.5484 Remote Similarity NPC110349
0.5437 Remote Similarity NPC65711
0.5421 Remote Similarity NPC244875
0.5398 Remote Similarity NPC198199
0.5354 Remote Similarity NPC211594
0.53 Remote Similarity NPC254540
0.5294 Remote Similarity NPC102028
0.5259 Remote Similarity NPC120952
0.5253 Remote Similarity NPC61791
0.5248 Remote Similarity NPC471079
0.5234 Remote Similarity NPC235575
0.5204 Remote Similarity NPC605067
0.52 Remote Similarity NPC172807
0.5196 Remote Similarity NPC67326
0.5192 Remote Similarity NPC46202
0.5093 Remote Similarity NPC101636
0.5052 Remote Similarity NPC229687

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC546553 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7849 Intermediate Similarity NPD7472 Pre-clinical
0.6842 Remote Similarity NPD7054 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data